What are the possible side effects of Axitinib?

Axitinib is an oral small molecule tyrosine kinase inhibitor mainly used to treat solid tumors such as advanced renal cell carcinoma. As a targeted drug, axitinib blocks tumor angiogenesis by inhibiting vascular endothelial growth factor receptor (VEGFR), thereby inhibiting tumor growth and spread. Despite its remarkable efficacy, axitinib will also cause certain side effects during clinical application. The frequency and severity of these adverse reactions vary depending on individual patients. Understanding these side effects can help patients and medical staff better manage and cope with discomfort during treatment.

First, one of the most common side effects of axitinib is high blood pressure. Because the drug inhibits vascular endothelial growth factor, it causes vasoconstriction and increased vascular resistance, thereby triggering an increase in blood pressure. Hypertension is more common in patients taking axitinib, and symptoms such as headache, dizziness, and blurred vision may occur. If high blood pressure is not effectively controlled, it may increase the risk of cardiovascular events and, in severe cases, even lead to heart failure or stroke. Therefore, patients need to monitor their blood pressure regularly during treatment and cooperate with antihypertensive drug treatment when necessary to ensure that their blood pressure is within a safe range.

Secondly, gastrointestinal reactions are also common side effects of axitinib, including diarrhea, nausea, vomiting, and loss of appetite. Diarrhea may cause patients to suffer from dehydration, electrolyte imbalance and other problems, affecting their health and treatment tolerance. To relieve these symptoms, patients should pay attention to dietary adjustments, avoid irritating foods, and use antidiarrheal and anti-nausea drugs under the guidance of a doctor. At the same time, maintain adequate fluid intake to prevent dehydration caused by diarrhea.

Third, axitinib may also cause fatigue and hand-foot syndrome. Fatigue often affects patients' quality of life, manifesting as persistent fatigue and decreased energy, which needs to be alleviated by adjusting daily routine and taking appropriate rest. Hand-foot syndrome is characterized by redness, swelling, pain, and desquamation of the skin on the palms and soles of the feet. In severe cases, it may even affect walking and daily activities. For hand-foot syndrome, patients can use moisturizers and topical medications to avoid excessive friction and irritation.

In addition, axitinib may also cause serious adverse reactions such as abnormal liver function, hypothyroidism, bleeding tendency and risk of thrombosis. Abnormal liver function is manifested by elevated transaminases in blood tests, which may affect liver health in severe cases, so liver function needs to be tested regularly during treatment. Hypothyroidism may present with symptoms such as fatigue, weight gain, cold intolerance, etc. If necessary, thyroid function testing and replacement therapy should be performed. In terms of blood system, axitinib may lead to an increased risk of bleeding and thrombosis. Patients and doctors need to pay close attention to related symptoms, such as abnormal bleeding, subcutaneous ecchymosis, and limb swelling.

In general, axitinib brings a variety of possible side effects while exerting anti-tumor effects. Patients should maintain close communication with their doctors during medication and report any symptoms of discomfort in a timely manner. Through reasonable side effect management and symptomatic treatment, adverse reactions can be minimized and the tolerability and efficacy of treatment can be improved. Only under the premise of ensuring safety can the therapeutic potential of axitinib be fully utilized and help patients better fight cancer.

Reference materials:https://en.wikipedia.org/wiki/Axitinib